Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Dragonfly Therapeutics
National Institutes of Health Clinical Center (CC)
Seagen Inc.
Roswell Park Cancer Institute
Eli Lilly and Company
Dana-Farber Cancer Institute
PMV Pharmaceuticals, Inc
NeoImmuneTech
Merck Sharp & Dohme LLC
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
Genmab
Tizona Therapeutics, Inc
BioInvent International AB
Essen Biotech
Ohio State University Comprehensive Cancer Center
IDEAYA Biosciences
Eli Lilly and Company
Seagen Inc.
Novartis